Skip to content

MENDD Tolerance Assessment Study

Michigan ENdoluminal Distraction Device (MENDD) Tolerance Assessment Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06185088
Enrollment
1
Registered
2023-12-29
Start date
2023-03-06
Completion date
2023-06-06
Last updated
2024-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Short Bowel Syndrome

Brief summary

This study will utilize approved devices in an off-label manner to create forces required to induce intestinal lengthening. Radial and longitudinal forces are both required, and two devices will be used to create forces in order to test tolerability of said forces. This is to provide evidence that humans could tolerate the forces produced by a proposed commercially built device. This study will test the hypothesis that radial and longitudinal forces necessary to produce enterogenesis will cause low levels of discomfort in healthy adults. Approved devices will be utilized in an off-label manner to reproduce forces similar to our novel medical device which is designed to treat short bowel syndrome (SBS). This trial will not be testing a treatment for SBS, and individuals with SBS are ineligible for recruitment.

Interventions

DEVICECoda® Balloon Catheters

A balloon device that will be introduced into participants' intestine over a guide wire to test the radial stretch of the small bowel.

DEVICEDouble Balloon Endoscope (DBE)

A balloon device that will be introduced retrograde through the ileostomy and the inter-balloon distance will be increased causing stretch on the intestine to test longitudinal stretch. The DBE will only be used if a participant tolerated the Coda® Balloon Catheter intervention.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Existing Ileostomy older than 6 weeks Undergoing any existing procedure in endoscopy suite or operating room.

Exclusion criteria

* Inflammatory bowel disease of small bowel Pregnant Short bowel syndrome Bleeding disorder Chronic pain disorder Individuals taking chronic pain medications including prescriptions, cannabinoids or over the counter. Individuals taking pain medications at the time of the procedure Cognitive Impairment to the extent that the questionnaire cannot be completed

Design outcomes

Primary

MeasureTime frameDescription
Discomfort as Assessed by Visual Analog Scale (VAS) for Radial Stretch1-2 MinutesParticipant discomfort will be assessed using VAS during radial stretch. The VAS is a scale ranging from 0 (no pain) to 10 (maximum pain).

Secondary

MeasureTime frameDescription
Discomfort as Assessed by Visual Analog Scale for Longitudinal StretchApproximately 1 minuteParticipant discomfort will be assessed using VAS during longitudinal stretch. The VAS is a scale ranging from 0 (no pain) to 10 (maximum pain).

Countries

United States

Participant flow

Participants by arm

ArmCount
Participants With Ostomies
Patients who have ostomies, and who are already undergoing a minor procedure for routine health screening or other health matters as standard of care. Coda® Balloon Catheters: A balloon device that will be introduced into participants' intestine over a guide wire to test the radial stretch of the small bowel. Double Balloon Endoscope (DBE): A balloon device that will be introduced retrograde through the ileostomy and the inter-balloon distance will be increased causing stretch on the intestine to test longitudinal stretch. The DBE will only be used if a participant tolerated the Coda® Balloon Catheter intervention.
1
Total1

Baseline characteristics

CharacteristicParticipants With Ostomies
Age, Customized
18 years to 99 years
1 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
United States
1 participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Discomfort as Assessed by Visual Analog Scale (VAS) for Radial Stretch

Participant discomfort will be assessed using VAS during radial stretch. The VAS is a scale ranging from 0 (no pain) to 10 (maximum pain).

Time frame: 1-2 Minutes

Population: Because only one participant was involved in the entire trial, showing data could violate privacy interests.

Secondary

Discomfort as Assessed by Visual Analog Scale for Longitudinal Stretch

Participant discomfort will be assessed using VAS during longitudinal stretch. The VAS is a scale ranging from 0 (no pain) to 10 (maximum pain).

Time frame: Approximately 1 minute

Population: Because only one participant was involved in the entire trial, showing data could violate privacy interests.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026